Concepedia

F. Patrick Carr

FP

3

Publications

53

Citations

3

H-Index

1986

Active since

Affiliations

Eli Lilly (United States)(Current)

F. Patrick Carr is an author at Eli Lilly (United States) specializing in natural sciences, pharmacotherapy, and drug discovery.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapyNatural SciencesMedicinal ChemistryOrganic ChemistryChemistryPhysiology

Publications per year

1986–1991

3

Publications

3

Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives

Robert D. Dillard, F. Patrick Carr, Doris McCullough et al. · Journal of Medicinal Chemistry · 1987 · 24 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmacological Study +14

Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-{[4-(1H-tetrazol-5-ylmethyl)phenoxy]methyl}phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4

Jerome H. Fleisch, Lynn E. Rinkema, Klaus D. Haisch et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1986 · 16 citations

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +11

(Phenylmethoxy)phenyl derivatives of w-oxo- and w-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists

Robert D. Dillard, R Hahn, Doris McCullough et al. · Journal of Medicinal Chemistry · 1991 · 13 citations

Organic Chemistry, Pharmacotherapy, Chemistry +17

Rows per page

1–3 of 3